secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001683168-25-000611
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma inks exclusive US distribution deal with WellSpring for Microcyn products
--------------------------------------------------------------------------------

- Exclusive US distribution agreement with WellSpring Pharmaceutical, effective Jan 29, 2025.
- Initial term of 2 years with three automatic one-year renewal periods.
- WellSpring to distribute Microcyn-based products through defined channels; Sonoma retains all IP.
- WellSpring must use commercially reasonable efforts and cannot sell competing hypochlorous acid products in those channels.
- Pricing, minimum quantities, and forecasts are set in confidential attachments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/0001683168-25-000611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825000611/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer